US Stock MarketDetailed Quotes

NRXP NRX Pharmaceuticals

Watchlist
  • 3.0200
  • -1.1600-27.75%
Close Apr 18 16:00 ET
  • 3.0500
  • +0.0300+0.99%
Pre 09:14 ET
28.90MMarket Cap-755P/E (TTM)

NRX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-37.21%27.84M
-55.44%4.41M
-36.46%5.81M
-14.71%8.19M
-39.92%9.44M
-61.71%44.34M
-81.33%9.89M
-54.52%9.14M
-43.92%9.6M
-38.66%15.71M
Selling and administrative expenses
-47.94%14.22M
-65.54%1.87M
-50.24%2.49M
-38.80%4.07M
-43.41%5.79M
-63.56%27.31M
-88.33%5.43M
-63.74%5.01M
-46.68%6.64M
386.53%10.22M
-General and administrative expense
-47.94%14.22M
-65.54%1.87M
-50.24%2.49M
-38.80%4.07M
-43.41%5.79M
-63.56%27.31M
-88.33%5.43M
-63.74%5.01M
-46.68%6.64M
386.53%10.22M
Research and development costs
-21.47%13.37M
-43.13%2.53M
-19.74%3.31M
30.93%3.87M
-33.43%3.65M
-15.95%17.03M
-30.52%4.46M
-34.21%4.13M
-36.51%2.96M
88.48%5.48M
Other operating expenses
--250K
--0
----
--250K
----
----
----
----
----
----
Operating profit
37.21%-27.84M
55.44%-4.41M
36.46%-5.81M
14.71%-8.19M
39.92%-9.44M
61.71%-44.34M
81.33%-9.89M
54.52%-9.14M
43.92%-9.6M
38.66%-15.71M
Net non-operating interest income expense
50.20%374K
-104.51%-6K
-16.84%79K
530.43%145K
5,300.00%156K
1,483.33%249K
6,750.00%133K
2,000.00%95K
560.00%23K
40.00%-3K
Non-operating interest income
98.39%494K
-43.08%74K
25.26%119K
530.43%145K
--156K
--249K
--130K
--95K
--23K
--0
Non-operating interest expense
--120K
2,766.67%80K
--40K
--0
--0
--0
-250.00%-3K
--0
--0
-40.00%3K
Other net income (expense)
-162.03%-2.69M
116.46%80K
-800.00%-333K
-125.97%-674K
-177.88%-1.76M
-80.96%4.33M
-102.15%-486K
99.78%-37K
-84.74%2.6M
1,767.77%2.26M
Gain on sale of security
-974.80%-2.69M
116.46%80K
-800.00%-333K
-681.03%-674K
-1,221.02%-1.76M
-114.78%-250K
-155.93%-486K
99.78%-37K
-99.33%116K
--157K
Special income (charges)
--0
--0
--0
--0
--0
-78.24%4.58M
--0
--0
798.31%2.48M
1,638.02%2.1M
-Less：Restructuring and merger&acquisition
--0
--0
--0
--0
--0
78.12%-4.58M
--0
--0
-798.31%-2.48M
---2.1M
Income before tax
24.16%-30.15M
57.70%-4.33M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
57.28%-39.75M
66.32%-10.24M
75.48%-9.08M
-5,816.95%-6.98M
47.24%-13.45M
Income tax
Net income
24.16%-30.15M
57.70%-4.33M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
57.28%-39.75M
66.32%-10.24M
75.48%-9.08M
-5,816.95%-6.98M
47.24%-13.45M
Net income continuous Operations
24.16%-30.15M
57.70%-4.33M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
57.28%-39.75M
66.32%-10.24M
75.48%-9.08M
-5,816.95%-6.98M
47.24%-13.45M
Minority interest income
Net income attributable to the parent company
24.16%-30.15M
57.70%-4.33M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
57.28%-39.75M
66.32%-10.24M
75.48%-9.08M
-5,816.95%-6.98M
47.24%-13.45M
Preferred stock dividends
Other preferred stock dividends
9K
0
Net income attributable to common stockholders
24.14%-30.16M
57.61%-4.34M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
88.61%-39.75M
66.32%-10.24M
75.48%-9.08M
97.27%-6.98M
47.24%-13.45M
Basic earnings per share
33.33%-4
66.67%-0.5
50.00%-0.7
-9.09%-1.2
23.81%-1.6
91.94%-6
70.99%-1.5
79.29%-1.4
98.21%-1.1
70.42%-2.1
Diluted earnings per share
33.33%-4
66.67%-0.5
50.00%-0.7
-9.09%-1.2
23.81%-1.6
91.94%-6
70.99%-1.5
79.29%-1.4
98.29%-1.1
70.42%-2.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -37.21%27.84M-55.44%4.41M-36.46%5.81M-14.71%8.19M-39.92%9.44M-61.71%44.34M-81.33%9.89M-54.52%9.14M-43.92%9.6M-38.66%15.71M
Selling and administrative expenses -47.94%14.22M-65.54%1.87M-50.24%2.49M-38.80%4.07M-43.41%5.79M-63.56%27.31M-88.33%5.43M-63.74%5.01M-46.68%6.64M386.53%10.22M
-General and administrative expense -47.94%14.22M-65.54%1.87M-50.24%2.49M-38.80%4.07M-43.41%5.79M-63.56%27.31M-88.33%5.43M-63.74%5.01M-46.68%6.64M386.53%10.22M
Research and development costs -21.47%13.37M-43.13%2.53M-19.74%3.31M30.93%3.87M-33.43%3.65M-15.95%17.03M-30.52%4.46M-34.21%4.13M-36.51%2.96M88.48%5.48M
Other operating expenses --250K--0------250K------------------------
Operating profit 37.21%-27.84M55.44%-4.41M36.46%-5.81M14.71%-8.19M39.92%-9.44M61.71%-44.34M81.33%-9.89M54.52%-9.14M43.92%-9.6M38.66%-15.71M
Net non-operating interest income expense 50.20%374K-104.51%-6K-16.84%79K530.43%145K5,300.00%156K1,483.33%249K6,750.00%133K2,000.00%95K560.00%23K40.00%-3K
Non-operating interest income 98.39%494K-43.08%74K25.26%119K530.43%145K--156K--249K--130K--95K--23K--0
Non-operating interest expense --120K2,766.67%80K--40K--0--0--0-250.00%-3K--0--0-40.00%3K
Other net income (expense) -162.03%-2.69M116.46%80K-800.00%-333K-125.97%-674K-177.88%-1.76M-80.96%4.33M-102.15%-486K99.78%-37K-84.74%2.6M1,767.77%2.26M
Gain on sale of security -974.80%-2.69M116.46%80K-800.00%-333K-681.03%-674K-1,221.02%-1.76M-114.78%-250K-155.93%-486K99.78%-37K-99.33%116K--157K
Special income (charges) --0--0--0--0--0-78.24%4.58M--0--0798.31%2.48M1,638.02%2.1M
-Less：Restructuring and merger&acquisition --0--0--0--0--078.12%-4.58M--0--0-798.31%-2.48M---2.1M
Income before tax 24.16%-30.15M57.70%-4.33M33.26%-6.06M-24.85%-8.72M17.91%-11.04M57.28%-39.75M66.32%-10.24M75.48%-9.08M-5,816.95%-6.98M47.24%-13.45M
Income tax
Net income 24.16%-30.15M57.70%-4.33M33.26%-6.06M-24.85%-8.72M17.91%-11.04M57.28%-39.75M66.32%-10.24M75.48%-9.08M-5,816.95%-6.98M47.24%-13.45M
Net income continuous Operations 24.16%-30.15M57.70%-4.33M33.26%-6.06M-24.85%-8.72M17.91%-11.04M57.28%-39.75M66.32%-10.24M75.48%-9.08M-5,816.95%-6.98M47.24%-13.45M
Minority interest income
Net income attributable to the parent company 24.16%-30.15M57.70%-4.33M33.26%-6.06M-24.85%-8.72M17.91%-11.04M57.28%-39.75M66.32%-10.24M75.48%-9.08M-5,816.95%-6.98M47.24%-13.45M
Preferred stock dividends
Other preferred stock dividends 9K0
Net income attributable to common stockholders 24.14%-30.16M57.61%-4.34M33.26%-6.06M-24.85%-8.72M17.91%-11.04M88.61%-39.75M66.32%-10.24M75.48%-9.08M97.27%-6.98M47.24%-13.45M
Basic earnings per share 33.33%-466.67%-0.550.00%-0.7-9.09%-1.223.81%-1.691.94%-670.99%-1.579.29%-1.498.21%-1.170.42%-2.1
Diluted earnings per share 33.33%-466.67%-0.550.00%-0.7-9.09%-1.223.81%-1.691.94%-670.99%-1.579.29%-1.498.29%-1.170.42%-2.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg